425P Five-year outcomes with delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD): a phase 1/2a study
Year: 2024
Type: article
Source: Neuromuscular Disorders
Authors: J. Mendell, Z. Sahenk, L. Lowes, N. Reash, M. Iammarino, L. Alfano, J. Signorovitch, J. Jin, P. Gao, S. Mason, J. Elkins, L. Rodino-Klapac
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4403139741